Skip Nav Destination
Issues
March 2019
-
Cover Image
Cover Image
Cover: A pregnant woman with a flower blossom on her glowing belly. Credit: Bull's Eye. For more information, please visit gettyimages.com.
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0149-5992
EISSN 1935-5548
In this Issue
In This Issue
In This Issue of Diabetes Care
Diabetes Care February 2019, Vol.42, 343-344. doi:https://doi.org/10.2337/dc19-ti03
Commentaries
Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes
Diabetes Care February 2019, Vol.42, 345-348. doi:https://doi.org/10.2337/dci18-0040
Therapeutic Inertia and the Legacy of Dysglycemia on the Microvascular and Macrovascular Complications of Diabetes
Diabetes Care February 2019, Vol.42, 349-351. doi:https://doi.org/10.2337/dci18-0030
Presidential Address
2018 Health Care & Education Presidential Address: The American Diabetes Association in the Era of Health Care Transformation
Diabetes Care February 2019, Vol.42, 352-358. doi:https://doi.org/10.2337/dci18-0051
Gestational Diabetes Mellitus: New Evidence for the Continuing Challenge
Lois Jovanovič, MD, MACE: Pioneer in the Field of Diabetes and Pregnancy and Beyond
Diabetes Care February 2019, Vol.42, 359-363. doi:https://doi.org/10.2337/dci18-0056
Probiotics for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Women: Findings From the SPRING Double-Blind Randomized Controlled Trial
Leonie K. Callaway; H. David McIntyre; Helen L. Barrett; Katie Foxcroft; Anne Tremellen; Barbara E. Lingwood; Jacinta M. Tobin; Shelley Wilkinson; Alka Kothari; Mark Morrison; Peter O’Rourke; Anita Pelecanos; Marloes Dekker Nitert
Diabetes Care January 2019, Vol.42, 364-371. doi:https://doi.org/10.2337/dc18-2248
Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Gestational Diabetes Mellitus and Childhood Glucose Metabolism
William L. Lowe, Jr.; Denise M. Scholtens; Alan Kuang; Barbara Linder; Jean M. Lawrence; Yael Lebenthal; David McCance; Jill Hamilton; Michael Nodzenski; Octavious Talbot; Wendy J. Brickman; Peter Clayton; Ronald C. Ma; Wing Hung Tam; Alan R. Dyer; Patrick M. Catalano; Lynn P. Lowe; Boyd E. Metzger; HAPO Follow-up Study Cooperative Research Group
Diabetes Care January 2019, Vol.42, 372-380. doi:https://doi.org/10.2337/dc18-1646
Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism
Denise M. Scholtens; Alan Kuang; Lynn P. Lowe; Jill Hamilton; Jean M. Lawrence; Yael Lebenthal; Wendy J. Brickman; Peter Clayton; Ronald C. Ma; David McCance; Wing Hung Tam; Patrick M. Catalano; Barbara Linder; Alan R. Dyer; William L. Lowe, Jr.; Boyd E. Metzger; HAPO Follow-Up Study Cooperative Research Group
Diabetes Care January 2019, Vol.42, 381-392. doi:https://doi.org/10.2337/dc18-2021
Much to HAPO FUS About: Increasing Maternal Glycemia in Pregnancy Is Associated With Worsening Childhood Glucose Metabolism
Diabetes Care February 2019, Vol.42, 393-395. doi:https://doi.org/10.2337/dci18-0064
Metformin for Gestational Diabetes Mellitus: Progeny, Perspective, and a Personalized Approach
Diabetes Care February 2019, Vol.42, 396-399. doi:https://doi.org/10.2337/dci18-0055
Clinical Care / Education / Nutrition / Psychosocial Research
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
Roy W. Beck; Richard M. Bergenstal; Tonya D. Riddlesworth; Craig Kollman; Zhaomian Li; Adam S. Brown; Kelly L. Close
Diabetes Care October 2018, Vol.42, 400-405. doi:https://doi.org/10.2337/dc18-1444
Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score
Suna Onengut-Gumuscu; Wei-Min Chen; Catherine C. Robertson; Jessica K. Bonnie; Emily Farber; Zhennan Zhu; Jorge R. Oksenberg; Steven R. Brant; S. Louis Bridges, Jr.; Jeffrey C. Edberg; Robert P. Kimberly; Peter K. Gregersen; Marian J. Rewers; Andrea K. Steck; Mary H. Black; Dana Dabelea; Catherine Pihoker; Mark A. Atkinson; Lynne E. Wagenknecht; Jasmin Divers; Ronny A. Bell; SEARCH for Diabetes in Youth; Type 1 Diabetes Genetics Consortium; Henry A. Erlich; Patrick Concannon; Stephen S. Rich
Diabetes Care January 2019, Vol.42, 406-415. doi:https://doi.org/10.2337/dc18-1727
Epidemiology / Health Services Research
The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study)
Neda Laiteerapong; Sandra A. Ham; Yue Gao; Howard H. Moffet; Jennifer Y. Liu; Elbert S. Huang; Andrew J. Karter
Diabetes Care August 2018, Vol.42, 416-426. doi:https://doi.org/10.2337/dc17-1144
Eye Care Utilization Among Insured People With Diabetes in the U.S., 2010–2014
Diabetes Care January 2019, Vol.42, 427-433. doi:https://doi.org/10.2337/dc18-0828
Type 2 Diabetes, but Not Insulin (Analog) Treatment, Is Associated With More Advanced Stages of Breast Cancer: A National Linkage of Cancer and Pharmacy Registries
Jetty A. Overbeek; Myrthe P.P. van Herk-Sukel; Pauline A.J. Vissers; Amber A.W.A. van der Heijden; Heleen K. Bronsveld; Ron M.C. Herings; Marjanka K. Schmidt; Giel Nijpels
Diabetes Care January 2019, Vol.42, 434-442. doi:https://doi.org/10.2337/dc18-2146
Pathophysiology / Complications
Impact of Early Diabetic Ketoacidosis on the Developing Brain
Tandy Aye; Paul K. Mazaika; Nelly Mauras; Matthew J. Marzelli; Hanyang Shen; Tamara Hershey; Allison Cato; Stuart A. Weinzimer; Neil H. White; Eva Tsalikian; Booil Jo; Allan L. Reiss; Diabetes Research in Children Network (DirecNet) Study Group
Diabetes Care December 2018, Vol.42, 443-449. doi:https://doi.org/10.2337/dc18-1405
A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
Maya Fayfman; Rodolfo J. Galindo; Daniel J. Rubin; Dara L. Mize; Isabel Anzola; Maria A. Urrutia; Clementina Ramos; Francisco J. Pasquel; J. Sonya Haw; Priyathama Vellanki; Heqiong Wang; Bonnie S. Albury; Rita Weaver; Saumeth Cardona; Guillermo E. Umpierrez
Diabetes Care January 2019, Vol.42, 450-456. doi:https://doi.org/10.2337/dc18-1760
Cardiovascular and Metabolic Risk
Long-term Absolute Risk for Cardiovascular Disease Stratified by Fasting Glucose Level
Michael P. Bancks; Hongyan Ning; Norrina B. Allen; Alain G. Bertoni; Mercedes R. Carnethon; Adolfo Correa; Justin B. Echouffo-Tcheugui; Leslie A. Lange; Donald M. Lloyd-Jones; John T. Wilkins
Diabetes Care January 2019, Vol.42, 457-465. doi:https://doi.org/10.2337/dc18-1773
Clusterin Impairs Hepatic Insulin Sensitivity and Adipocyte Clusterin Associates With Cardiometabolic Risk
David Bradley; Alecia Blaszczak; Zheng Yin; Joey Liu; Joshua J. Joseph; Valerie Wright; Kajol Anandani; Bradley Needleman; Sabrena Noria; David Renton; Martha Yearsley; Stephen T.C. Wong; Willa A. Hsueh
Diabetes Care January 2019, Vol.42, 466-475. doi:https://doi.org/10.2337/dc18-0870
Secular TRends in DiabEtes in India (STRiDE–I): Change in Prevalence in 10 Years Among Urban and Rural Populations in Tamil Nadu
Arun Nanditha; Chamukuttan Snehalatha; Krishnamoorthy Satheesh; Priscilla Susairaj; Mary Simon; Lakshminarayanan Vijaya; Arun Raghavan; Ramachandran Vinitha; Ambady Ramachandran
Diabetes Care January 2019, Vol.42, 476-485. doi:https://doi.org/10.2337/dc18-1559
Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study
Justin B. Echouffo-Tcheugui; Songzhu Zhao; Guy Brock; Roland A. Matsouaka; David Kline; Joshua J. Joseph
Diabetes Care January 2019, Vol.42, 486-493. doi:https://doi.org/10.2337/dc18-1430
Errata
Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042–2050
Lennart Tonneijck; Mark M. Smits; Marcel H.A. Muskiet; Trynke Hoekstra; Mark H.H. Kramer; A.H. Jan Danser; Piet M. ter Wee; Michaela Diamant; Jaap A. Joles; Daniel H. van Raalte
Diabetes Care January 2019, Vol.42, 494. doi:https://doi.org/10.2337/dc19-er03
Erratum. Elevated Serum Xanthine Oxidase Activity Is Associated With the Development of Type 2 Diabetes: A Prospective Cohort Study. Diabetes Care 2018;41;884–890
Xue Li; Xing Meng; Xiangchun Gao; Xiuyu Pang; Yanjiao Wang; Xiaoyan Wu; Xinrui Deng; Qiao Zhang; Changhao Sun; Ying Li
Diabetes Care January 2019, Vol.42, 494. doi:https://doi.org/10.2337/dc19-er03a
Erratum. Increased Prevalence of Type 2 Diabetes–Related Complications in Combined Type 2 Diabetes and Sickle Cell Trait. Diabetes Care 2018;41:2595—2602
Sarah C. Skinner; Mor Diaw; Vincent Pialoux; Maïmouna Ndour Mbaye; Pauline Mury; Philomène Lopez; Delphine Bousquet; Fatou Gueye; Demba Diedhiou; Philippe Joly; Céline Renoux; Djiby Sow; Saliou Diop; Brigitte Ranque; Agnès Vinet; Abdoulaye Samb; Nicolas Guillot; Philippe Connes
Diabetes Care January 2019, Vol.42, 494. doi:https://doi.org/10.2337/dc19-er03b
Issues and Events
e-Letters
Observations
Material Need Insecurity and Its Concurrent Barriers to Diabetes Management Among Low-Income Latino Adults Receiving Medical Care
Diabetes Care January 2019, Vol.42, e31-e33. doi:https://doi.org/10.2337/dc18-1583
Event Rates and Risk Factors for the Development of Diabetic Ketoacidosis in Adult Patients With Type 1 Diabetes: Analysis From the DPV Registry Based on 46,966 Patients
Hannes Kalscheuer; Jochen Seufert; Stefanie Lanzinger; Joachim Rosenbauer; Wolfram Karges; Dominik Bergis; Julia K. Mader; Stefan Zimny; Sebastian M. Schmid; Michael Hummel; Wolfgang Kerner; Reinhard W. Holl; on behalf of the DPV Initiative
Diabetes Care January 2019, Vol.42, e34-e36. doi:https://doi.org/10.2337/dc18-1160
Center Size and Glycemic Control: An International Study With 504 Centers From Seven Countries
Niels H. Birkebaek; Julia M. Hermann; Lena Hanberger; Dimitrios Charalampopoulos; Reinhard W. Holl; Torild Skrivarhaug; Karin Aakesson; Justin T. Warner; Ann K. Drivvoll; Ann-Marie Svensson; Terence Stephenson; Sabine E. Hofer; Siri Fredheim; Siv J. Kummernes; Rakesh Amin; Birgit Rami-Merhar; Anders Johansen; Thomas M. Kapellen; Doerte Hilgard; Knut Dahl-Jørgensen; Elke Froehlich-Reiterer; Maria Fritsch; Ragnar Hanas; Jannet Svensson
Diabetes Care January 2019, Vol.42, e37-e39. doi:https://doi.org/10.2337/dc18-1253
Detailed Time Course of Decline in Serum C-Peptide Levels in Anti–Programmed Cell Death-1 Therapy–Induced Fulminant Type 1 Diabetes
Daigo Saito; Yoichi Oikawa; Yuya Yano; Yuichi Ikegami; Atsushi Satomura; Masashi Isshiki; Susumu Kurihara; Ikuo Inoue; Mitsuhiko Noda; Akira Shimada
Diabetes Care January 2019, Vol.42, e40-e41. doi:https://doi.org/10.2337/dc18-1673
Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy: A Subanalysis of the EMPA-REG OUTCOME Trial
Subodh Verma; C. David Mazer; Deepak L. Bhatt; Satish R. Raj; Andrew T. Yan; Atul Verma; Ele Ferrannini; Gudrun Simons; Jisoo Lee; Bernard Zinman; Jyothis T. George; David Fitchett
Diabetes Care January 2019, Vol.42, e42-e44. doi:https://doi.org/10.2337/dc18-1959
Comments and Responses
Comment on Pongrac Barlovic et al. The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up. Diabetes Care 2018;41:2487–2494
Marion Camoin; Marie-Noelle Delyfer; Jean-François Korobelnik; Kamel Mohammedi; Laurence Blanco; Ninon Foussard; Pauline Poupon; Marie Monlun; Magalie Haissaguerre; Vincent Rigalleau
Diabetes Care February 2019, Vol.42, e48. doi:https://doi.org/10.2337/dc18-2202
